XML 22 R2.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF EARNINGS - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Net Sales $ 19,318 $ 17,798
Cost of Products Sold 9,142 8,723
Selling, General and Administrative Expense 4,895 4,785
Operating Income 5,281 4,290
Interest Expense (136) (108)
Interest Income 10 58
Other Non-operating Income/(Loss), Net 142 103
Earnings/(Loss) from Continuing Operations Before Income Taxes 5,297 4,343
Income Taxes on Continuing Operations 989 726
Net Earnings 4,308 3,617
Net Income (Loss) Attributable to Noncontrolling Interest $ 31 $ 24
Basic Net Earnings Per Common Share    
Basic Net Earnings/(Loss) Per Common Share [1] $ 1.69 $ 1.41 [2]
Diluted Net Earnings Per Common Share    
Diluted Net Earnings/(Loss) Per Common Share [1] $ 1.63 $ 1.36 [2]
Diluted Weighted Average Common Shares Outstanding 2,625.3 2,647.5
Noncontrolling Interest [Member]    
Net Earnings $ 31 $ 24
Net Income (Loss) Attributable to Noncontrolling Interest   24
Retained Earnings [Member]    
Net Earnings $ 4,277 3,593
Net Earnings Attributable to Procter & Gamble   $ 3,593
[1] Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
[2] Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.